Bone marrow stromal cells from myeloma patients support the growth of myeloma stem cells

Stem Cells and Development

Volumn 19, Issue 9, 2010, Pages 1289-1296

  Feng, Yongdong ^a,b   Wen, Jianguo ^a   Mike, Perez ^a   Choi, Dong Soon ^a   Eshoa, Camellia ^c   Shi, Zheng Zheng ^a   Zu, Youli ^a,d   Chang, Chung Che ^a,d  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c Columbia St Mary's ^*  (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; HOE 33342; MITOGEN ACTIVATED PROTEIN KINASE; PLERIXAFOR;

ANIMAL CELL; ARTICLE; BONE MARROW STROMAL CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER PATIENT; CELL FUNCTION; CELL GROWTH; CELL MATURATION; CELL POPULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MULTIPLE MYELOMA; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; STAINING; STROMA CELL;

AGED; AGED, 80 AND OVER; ANIMALS; ANTINEOPLASTIC AGENTS; BONE MARROW CELLS; CASE-CONTROL STUDIES; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; HETEROCYCLIC COMPOUNDS; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASTIC STEM CELLS; STROMAL CELLS; TUMOR MICROENVIRONMENT; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77956431440     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2010.0010     Document Type: Article

References (31)

1. Adams JM, PN Kelly, A Dakic, S Carotta, SL Nutt and A Strasser . ( 2008 ). Role of "cancer stem cells" and cell survival in tumor development and maintenance . Cold Spring Harb Symp Quant Biol 73 : 451-459 .
2. Dick JE . ( 2008 ). Stem cell concepts renew cancer research . Blood 112 : 4793-4807 .
3. Matsui W, CA Huff, Q Wang, MT Malehorn, J Barber, Y Tanhehco, BD Smith, CI Civin and RJ Jones . ( 2004 ). Characterization of clonogenic multiple myeloma cells . Blood 103 : 2332-2336 .
4. Matsui W, Q Wang, JP Barber, S Brennan, BD Smith, I Borrello, I McNiece, L Lin, RF Ambinder, C Peacock, DN Watkins, CA Huff and RJ Jones . ( 2008 ). Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance . Cancer Res 68 : 190-197 .
5. Laubach JP, A Mahindra, CS Mitsiades, RL Schlossman, NC Munshi, IM Ghobrial, N Carreau, T Hideshima, KC Anderson and PG Richardson . ( 2009 ). The use of novel agents in the treatment of relapsed and refractory multiple myeloma . Leukemia 23 : 2222-2232 .
6. Jones DL and AJ Wagers . ( 2008 ). No place like home: anatomy and function of the stem cell niche . Nat Rev Mol Cell Biol 9 : 11-21 .
7. Scadden DT . ( 2006 ). The stem-cell niche as an entity of action . Nature 441 : 1075-1079 .
8. Gunn WG, A Conley, L Deininger, SD Olson, DJ Prockop and CA Gregory . ( 2006 ). A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-a potential role in the development of lytic bone disease and tumor progression in multiple myeloma . Stem Cells 24 : 986-991 .
9. Phinney DG and DJ Prockop . ( 2007 ). Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair - current views . Stem Cells 2896-2902
10. Kopp HG, ST Avecilla, AT Hooper and S Rafi i . ( 2005 ). The bone marrow vascular niche: home of HSC differentiation and mobilization . Physiology 20 : 349-356 .
11. Pedemonte E, F Benvenuto, S Casazza, G Mancardi, JR Oksenberg, A Uccelli and SE Baranzini . ( 2007 ). The molecular signature of therapeutic mesenchymal stem cells exposes the architecture of the hematopoietic stem cell niche synapse . BMC Genomics 8 : 65 .
12. Etheridge SL, GJ Spencer, DJ Heath and PG Genever . ( 2004 ). Expression profi ling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells . Stem Cells 22 : 849-860 .
13. Soeda A, M Park, D Lee, A Mintz, A Androutsellis-Theotokis, RD McKay, J Engh, T Iwama, T Kunisada, AB Kassam, IF Pollack and DM Park . ( 2009 ). Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha . Oncogene 28 : 3949-3959 .
14. Katoh Y and M Katoh . ( 2008 ). Hedgehog signaling, epithelialto- mesenchymal transition and miRNA (review) . Int J Mol Med 22 : 271-275 .
15. Trowbridge JJ, MP Scott and M Bhatia . ( 2006 ). Hedgehog modulates cell cycle regulators in stem cells to control hematopoietic regeneration . Proc Natl Acad Sci USA 103 : 14134-14139 .
16. Alsayed Y, H Ngo, J Runnels, X Leleu, UK Singha, CM Pitsillides, JA Spencer, T Kimlinger, JM Ghobrial, X Jia, G Lu, M Timm, A Kumar, D Cote, I Veilleux, KE Hedin, GD Roodman, TE Witzig, AL Kung, T Hideshima, KC Anderson, CP Lin and IM Ghobrial . ( 2007 ). Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma . Blood 109 : 2708-2717 .
17. Hideshima T, C Mitsiades, G Tonon, PG Richardson and KC Anderson . ( 2007 ). Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets . Nat Rev Cancer 7 : 585-598 .
18. Mitsiades CS, DW McMillin, S Klippel, T Hideshima, D Chauhan, PG Richardson, NC Munshi and KC Anderson . ( 2007 ). The role of the bone marrow microenvironment in the pathophysiology of myeloma and its signifi cance in the development of more effective therapies . Hematol Oncol Clin North Am 21 : 1007-34
19. Podar K, PG Richardson, T Hideshima, D Chauhan and KC Anderson . ( 2007 ). The malignant clone and the bone-marrow environment . Best Pract Res Clin Haematol 20 : 597-612 .
20. Corre J, K Mahtouk, M Attal, M Gadelorge, A Huynh, S Fleury-Cappellesso, C Danho, P Laharrague, B Klein, T Reme and P Bourin . ( 2007 ). Bone marrow mesenchymal stem cells are abnormal in multiple myeloma . Leukemia 21 : 1079-1088 .
21. Hirschmann-Jax C, AE Foster, GG Wulf, MA Goodell and MK Brenner . ( 2005 ). A distinct "side population" of cells in human tumor cells: implications for tumor biology and therapy . Cell Cycle 4 : 203-205 .
22. Goodell MA, S McKinney-Freeman and FD Camargo . ( 2005 ). Isolation and characterization of side population cells . Methods Mol Biol 290 : 343-352 .
23. Berlin O, D Samid, R Donthineni-Rao, W Akeson, D Amiel and VL Woods Jr . ( 1993 ). Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice . Cancer Res 53 : 4890-4895 .
24. Feng Y, G Ofek, DS Choi, J Wen, J Hu, H Zhao, Y Zu, KA Athanasiou and CC Chang . ( 2009 ). Unique biomechanical interactions between myeloma cells and bone marrow stroma cells . Prog Biophys Mol Biol . [Epub ahead of print]
25. Luo M and JL Guan . ( 2009 ). Focal adhesion kinase: A prominent determinant in breast cancer initiation, progression and metastasis. Cancer Lett . [Epub ahead of print]
26. Savas B, PE Kerr and HF Pross . ( 2006 ). Lymphokine-activated killer cell susceptibility and adhesion molecule expression of multidrug resistant breast carcinoma . Cancer Cell Int 6 : 24 .
27. Pontier SM and WJ Muller . ( 2009 ). Integrins in mammary-stemcell biology and breast-cancer progression - a role in cancer stem cells? J Cell Sci 122 ( Pt 2 ): 207-214 .
28. Chatterjee M, T Stuhmer, P Herrmann, K Bommert, B Dorken and RC Bargou . ( 2004 ). Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells . Blood 104 : 3712-3721 .
29. Menu E, R Kooijman, E Van Valckenborgh, K Asosingh, M Bakkus, B Van Camp and K Vanderkerken . ( 2004 ). Specifi c roles for the PI3K and the MEK-ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model . Br J Cancer 90 : 1076-1083 .
30. Song L, Y Li and B Shen . ( 2002 ). Protein kinase ERK contributes to differential responsiveness of human myeloma cell lines to IFNalpha . Cancer Cell Int 2 : 9 .
31. Burger M, A Glodek, T Hartmann, A Schmitt-Graff, LE Silberstein, N Fujii, TJ Kipps and JA Burger. (2003). Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. Oncogene 22:8093-8101.